Wegovy 1mg dose: how many clicks, what it means, and the decision ahead

1mg is the third dose step in Wegovy's five-stage titration schedule: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg.
Each Wegovy pen uses a click-dial mechanism; the number of audible clicks corresponds to the dose selected — check your Patient Information Leaflet for the exact click count for your pen type.
The 1mg stage typically lasts around four weeks before your prescriber considers moving you to 1.7mg, subject to tolerability.
Dose timing and any adjustments are clinical decisions, if you are unsure whether your dose is right, speak to your prescriber before changing anything.

At the 1mg dose of Wegovy, your pen delivers semaglutide at the third step of the standard titration schedule — past the 0.25mg and 0.5mg starter stages, but still short of the 1.7mg and 2.4mg maintenance doses that follow. How many clicks you turn the dose dial, and what that number tells you about where you are in treatment, is a practical question worth answering clearly. Wegovy is a prescription-only medicine; your prescriber sets the timing and pace of any dose change based on how your body has responded.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding the 1mg click-dial, when to move on, and when to pause

What the click mechanism actually does at 1mg

Wegovy's pre-filled pen uses a turn-and-click dose dial rather than a plunger you depress manually. When you set your dose, you rotate the dial until it reads your prescribed amount, and the clicks you feel and hear mark each increment as the dial turns. The number of clicks to reach 1mg is fixed by the pen's mechanical design, it isn't a number you should guess or count from memory. The right reference is always the Patient Information Leaflet inside your box, which sets out the exact click sequence for your specific pen.

A quick habit worth building: before every injection, hold the pen up to the light and confirm the dose window shows the correct number before you press the button. It takes about five seconds and removes any uncertainty. The click count for a 1mg Wegovy dose is explained in full on a dedicated page if you want the specifics alongside the dial instructions.

One thing that sometimes catches people out: the 1mg Wegovy injection dose is not the same as the 1mg semaglutide oral tablet used for type 2 diabetes (that's Rybelsus, a separate product with a different licensed use). Wegovy injections and Rybelsus tablets are distinct medicines for distinct purposes, even though both contain semaglutide.

Where 1mg sits in the titration journey (and how the decision to move on is made

The titration schedule exists because semaglutide's most common side effects) nausea, loose stools, indigestion, are dose-related and tend to settle if the body is brought up gradually. The full Wegovy dose schedule covers all five steps, but the essential logic is that each stage lasts roughly four weeks before your prescriber reviews whether you are ready to step up.

At 1mg, two things are being assessed: tolerability (are the gastrointestinal side effects manageable?) and early response. Neither is something you decide alone. If the 1mg stage has gone smoothly and your prescriber is happy with how things are progressing, the next discussion will likely be about moving to 1.7mg. If side effects have been difficult, staying at 1mg a little longer is a legitimate clinical choice, the schedule is a guide, not a deadline.

The relationship between clicks and dosage across the pen is worth understanding because it helps you feel confident at each stage rather than uncertain about whether you have dialled correctly. That confidence matters; a missed or incorrectly set dose is more disruptive than a slight delay in titrating.

Side effects at the 1mg stage: what is normal and what needs attention

Gastrointestinal effects are the most commonly reported reactions to semaglutide. At 1mg (a step up from 0.5mg) some people notice they return temporarily: a few days of nausea, reduced appetite, or looser stools. For most people these ease within a week or two as the body adjusts, according to NHS guidance on semaglutide.

Less common but worth knowing: if you experience severe, persistent stomach pain that reaches through to your back, seek medical help promptly. The MHRA highlighted acute pancreatitis as an infrequent but serious potential side effect of GLP-1 medicines in a Drug Safety Update issued in January 2026, it is rare, but the symptom pattern is distinctive and warrants urgent attention.

Staying well hydrated during any period of nausea reduces the risk of dehydration, particularly if vomiting occurs. Eating smaller meals and avoiding very fatty food tends to make the 1mg stage more comfortable. If you have concerns about how you are tolerating the dose, your prescriber is the right person to contact, not a forum, not the leaflet alone. You can explore general information about how Wegovy works and what to expect across the treatment course if you want broader context.

After 1mg: the path to maintenance and what shapes the next steps

The 1.7mg and 2.4mg doses that follow 1mg are where the majority of clinical weight-loss results are achieved. The landmark STEP 1 trial, published in the New England Journal of Medicine, reported an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, a figure that involved the full titration journey, not any single stage in isolation. Getting through 1mg comfortably is part of reaching that point.

For people curious about what the 2.4mg maintenance dose looks like on the dial, or wondering about the 1.7mg step that precedes it, those pages cover the click mechanics in the same practical detail. The 1mg click-by-click guidance is there if you want to revisit the mechanics for this specific stage.

Questions about cost at different stages of treatment (whether buying additional pens for a longer titration period changes the overall expense) are covered on the Wegovy price page. If you are considering starting treatment or have been on 1mg and want a clinical review before moving forward, you can check your eligibility with our prescribers, no obligation, and the consultation is free.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions